World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
7117
World Ranking
4793
National Ranking
2149

Raja Rajalingam publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Raja Rajalingam sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 209 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Raja Rajalingam D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Raja Rajalingam sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Raja Rajalingam is affiliated with the University of California, San Francisco in the United States. Their research spans mainly the fields of Medicine and Immunology and Microbiology, with significant contributions in subfields such as Immunology, Hematology, Transplantation, Molecular Biology, and Surgery.

The scientist's work addresses a range of topics including:

  • Renal Transplantation Outcomes and Treatments
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction
  • Hemophilia Treatment and Research
  • Hematopoietic Stem Cell Transplantation
  • Transplantation: Methods and Outcomes
  • Platelet Disorders and Treatments

Recent publications by Raja Rajalingam include the following papers:

  • "Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses," 2023, Cell Reports
  • "Hematopoietic Stem Cell Factors: Their Functional Role in Self-Renewal and Clinical Aspects," 2022, Frontiers in Cell and Developmental Biology
  • "Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression," 2023, Nature Biotechnology
  • "Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19," 2022, Frontiers in Genetics
  • "KIR-HLA gene diversities and susceptibility to lung cancer," 2022, Scientific Reports

Rajalingam frequently publishes in several scientific venues, including:

  • American Journal of Transplantation
  • Human Immunology
  • Frontiers in Genetics
  • Blood
  • Scientific Reports

Collaborations are a significant aspect of their research efforts. Frequent co-authors include:

  • Bernadette W. Luu
  • John Blangero
  • Tom E. Howard
  • Denice Kong
  • Marcio Almeida

This profile reflects a comprehensive research trajectory involving immune system functions, transplantation biology, and hematopoietic studies, combined with both clinical and molecular perspectives across multiple specialized domains.

Best Publications

  • The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans

    Laurent Abi-Rached;Matthew J. Jobin;Matthew J. Jobin;Subhash Kulkarni;Alasdair McWhinnie

  • Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism

    Clair M. Gardiner;Lisbeth A. Guethlein;Heather G. Shilling;Marcelo Pando

  • Rapid Evolution of NK Cell Receptor Systems Demonstrated by Comparison of Chimpanzees and Humans

    Salim I Khakoo;Raja Rajalingam;Benny P Shum;Kristin Weidenbach

  • Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

    Jason Dehn;Stephen Spellman;Carolyn K. Hurley;Bronwen E. Shaw

  • Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression.

    Makoto Yawata;Nobuyo Yawata;Karina L. McQueen;Nathalie W. Cheng

  • Distinctive KIR and HLA diversity in a panel of north Indian Hindus

    Raja Rajalingam;Peter Krausa;Heather G. Shilling;Jason B. Stein

  • Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.

    Zinal S. Chheda;Gary Kohanbash;Gary Kohanbash;Kaori Okada;Naznin Jahan

  • Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans

    Zeying Du;David W. Gjertson;Elaine F. Reed;Raja Rajalingam

  • Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing

    Paul J Norman;Jill A Hollenbach;Neda Nemat-Gorgani;Wesley M Marin

  • Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells.

    Yi-Ping Jin;Michael C Fishbein;Jonathan W Said;Peter T Jindra

  • Domain Shuffling Has Been the Main Mechanism Forming New Hominoid Killer Cell Ig-Like Receptors

    Raja Rajalingam;Peter Parham;Laurent Abi-Rached

  • KIR2DL5, a Novel Killer-Cell Receptor with a D0-D2 Configuration of Ig-Like Domains

    Carlos Vilches;Raja Rajalingam;Markus Uhrberg;Clair M. Gardiner

  • KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.

    Jeanette E. Boudreau;Fabio Giglio;Ted A. Gooley;Philip A. Stevenson

  • Polymerase Chain Reaction-Based Sequence-Specific Oligonucleotide Hybridization Analysis of HLA Class II Antigens in Pulmonary Tuberculosis: Relevance to Chemotherapy and Disease Severity

    R. Rajalingam;N. K. Mehra;R. C. Jain;V. P. Myneedu

  • Conservation and Variation in Human and Common Chimpanzee CD94 and NKG2 Genes

    Benny P. Shum;Laura R. Flodin;David G. Muir;Raja Rajalingam

  • Immunogenetics as a tool in anthropological studies.

    Alicia Sanchez-Mazas;Marcelo Fernandez-Viña;Derek Middleton;Jill A Hollenbach

  • Short KIR haplotypes in pygmy chimpanzee (Bonobo) resemble the conserved framework of diverse human KIR haplotypes.

    Raja Rajalingam;Mei Hong;Erin J. Adams;Benny P. Shum

  • Human diversity of killer cell immunoglobulin-like receptors and disease

    Raja Rajalingam

  • Allele-Level Haplotype Frequencies and Pairwise Linkage Disequilibrium for 14 KIR Loci in 506 European-American Individuals

    Cynthia Vierra-Green;David Roe;Lihua Hou;Carolyn Katovich Hurley

  • Transporter associated with antigen-processing (TAP) genes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis.

    R. Rajalingam;D. P. Singal;N. K. Mehra

  • Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations.

    Raja Rajalingam;Zeying Du;Ashley Meenagh;Lihui Luo

Frequent Co-Authors

Elaine F. Reed
Elaine F. Reed University of California, Los Angeles
Narinder K. Mehra
Narinder K. Mehra All India Institute of Medical Sciences
Peter Parham
Peter Parham Stanford University
John P. Roberts
John P. Roberts University of California, San Francisco
John Blangero
John Blangero The University of Texas Rio Grande Valley
Lisbeth A. Guethlein
Lisbeth A. Guethlein Stanford University
Jeffrey A. Golden
Jeffrey A. Golden Brigham and Women's Hospital
Eugene Maraskovsky
Eugene Maraskovsky CSL (United Kingdom)
Jonathan Braun
Jonathan Braun Cedars-Sinai Medical Center
Stephen R. Spellman
Stephen R. Spellman Medical College of Wisconsin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Many students consider nursing programs that complement immunological knowledge, especially accelerated tracks that fast-track their entry into clinical settings. Resources like easiest accelerated nursing programs offer valuable insights for prospective students seeking efficient routes into nursing careers.

Entry-level nursing roles also provide foundational experience in patient care and immunological applications. Programs such as lpn schools easy to get into highlight accessible options for beginning a healthcare profession with relatively low barriers to entry.

For professionals looking to advance, what is the easiest np program explores pathways to becoming a nurse practitioner (NP). Specializing as an NP with a focus on immunology-related fields can significantly enhance clinical expertise and career prospects.

Specifically, mental health intersects with immunology in areas like neuroimmunology. Online degrees such as those featured in the best psychiatric mental health nurse practitioner programs online can provide specialized skills alongside strong clinical placements, making them ideal choices for those pursuing integrated healthcare careers.

Best Scientists Citing Raja Rajalingam

Trending Scientists